Search
Developing a Corporate AI Policy Join Association of Corporate Counsel, along with inside and outside counsel presenters, as they discuss implementing best practices and responsible use policies to manage the risk of utilizing AI in the workplace. Speakers: Matthew Kohel, Partner, Intellectual...
Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the second quarter of 2023. If you would like to discuss...
This program discusses the basics of IT contracts for lawyers who are not IT specialists. Our presenters discussed some fundamental differences between traditional software licenses vs. agreements for Software-as-a-Service (SaaS) and cloud computing applications, how to address critical operational...
IP INSIGHTS: PATENTING IN THE AGE OF ARTIFICIAL INTELLIGENCE (AI) This month, Brian Landry will join Diane Harmon on IP Insights for an exciting session: Patenting in the Age of Artificial Intelligence (AI). Brian and Diane will explore the intersection between AI and patent law, and provide...
The use of artificial intelligence (AI) to generate creative works raises interesting legal challenges to the protection of intellectual property. The plain language of the Copyright Act presents obstacles to artists who may use generative AI as part of their creative process. The U.S. Copyright...
The use of artificial intelligence (AI) to create works of art creates interesting legal challenges to the protection of intellectual property. A copyright infringement class action lawsuit has been filed against providers of AI software that is used to generate visual works of art based on...
The use of artificial intelligence (AI) in health care, and specifically, as the utilization of software in medical devices continues to increase. Machine learning (ML) is a branch of AI in which computer systems automatically adapt, improve, and make predictions by applying algorithms to analyze...
The use of artificial intelligence (AI) to create works of art and inventions raises interesting legal challenges to the protection of intellectual property (IP). The plain language of the Copyright Act and Patent Act present obstacles to inventors and artists who may use or be AI systems. Recent...
Darius Gambino with Danny Cevallos - on Andy Warhol/Prince SCOTUS Case and Copyright Law in Art Danny Cevallos guest hosts the Michael Smerconish Program where he invites Saul Ewing's Darius Gambino to talk copyright law in art and music. Original air date, 14 October 2022.
Laurie Kamaiko advises clients on emerging and complex risks associated with cybersecurity and privacy incidents and the rapidly developing legal landscape. She helps them limit their exposure to such risks and respond to incidents and related litigation. Laurie has extensive experience in...
Sherry Flax concentrates her practice on matters dealing with intellectual property law, with an emphasis on trademarks and copyrights. She assists clients in securing and protecting their rights in commercially valuable property through U.S. and international trademarks and copyrights, domain names...
Francelina Perdomo Klukosky represents individuals and corporate creators in protecting their intellectual property assets and assisting with their business transactions and litigation. Drawing on more than two decades of legal experience and her personal passion for technology and innovation and...
Austin Strine represents clients in complex civil litigation in state and federal courts. His experience includes matters ranging from data privacy and cybersecurity issues and commercial breach of contract claims to corporate and shareholder disputes and business defamation cases. He also...
Michelle Streifthau-Livizos represents clients in litigation matters, including disputes involving the Hatch-Waxman Act, patents, copyrights and trademarks. She handles cases involving various types of technology, including representations of pharmaceutical companies, life sciences companies...